pentaerythritol tetranitrate has been researched along with Pregnancy in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Brodowski, L; Condic, M; de Vries, L; Delius, M; Eckmann-Scholz, C; Friebe-Hoffmann, U; Groten, T; Hoopmann, M; Hübener, C; Jäger, Y; Kagan, KO; Komar, M; Kraft, K; Lato, K; Lehmann, T; Pecks, U; Schlembach, D; Schleußner, E; Schrey-Petersen, S; Seeger, S; Seliger, G; Sroka, D; Städtler, M; Strizek, B; Tauscher, A; Verlohren, S; von Kaisenberg, CS; Winkler, JL | 1 |
| Costa, ML; Guida, JPS; Silva, CEBD | 1 |
| Arriaga, WE; Carrillo, G; Castro, R; Cecatti, JG; Chevez, LM; Colomar, M; Costa, ML; Cruz, CM; de Mucio, B; Gonzalez, F; Guadalupe, RM; Guida, JP; Lopez, R; Luz, AG; Mainero, L; Moreno, A; Ochoa, C; Rizo, U; Saint Hillaire, EE; Serruya, SJ; Sosa, C; Sousa, MH; Souza, RT; Stefan, A | 1 |
| Groten, T; Lehmann, T; Schleußner, E | 1 |
| Abbasi, M; Abdi, F; Fashami, MA; Rahnemaei, FA | 1 |
| Chen, M; Daiber, A; Li, H; Man, AWC; Münzel, T; Reifenberg, G; Wu, Z; Xia, N; Zhou, Y | 1 |
| Bowkalow, S; Groten, T; Kähler, C; Lehmann, T; Schleussner, E; Schneider, U | 1 |
| Groten, T; Kähler, C; Lehmann, T; Schlembach, D; Schleussner, E; Schneider, U | 1 |
| Bauersachs, J; Widder, JD | 1 |
| Daiber, A; Förstermann, U; Li, H; Münzel, T; Reifenberg, G; Siuda, D; Wu, Z; Xia, N | 1 |
| Crouse, LC; Johnson, MS; LaFiandra, EM; McFarland, CA; Quinn, MJ | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Bizzarri, DV; Giuffrida, JG; Grimaldi, RD; Lagman, L | 1 |
2 review(s) available for pentaerythritol tetranitrate and Pregnancy
| Article | Year |
|---|---|
Factors effective in the prevention of Preeclampsia:A systematic review.
Topics: Arginine; Calcium; Drug Therapy, Combination; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; Pentaerythritol Tetranitrate; Pre-Eclampsia; Pregnancy; Prenatal Care; Vitamin D; Yoga | 2020 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
4 trial(s) available for pentaerythritol tetranitrate and Pregnancy
| Article | Year |
|---|---|
Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
Topics: Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Pentaerythritol Tetranitrate; Perfusion; Perinatal Death; Placenta; Placentation; Pregnancy; Premature Birth | 2023 |
Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial.
Topics: Adult; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Age; Outcome Assessment, Health Care; Pentaerythritol Tetranitrate; Perfusion Imaging; Placenta; Placental Insufficiency; Pregnancy; Pregnancy Outcome; Ultrasonography, Doppler; Ultrasonography, Prenatal; Uterine Artery; Vasodilator Agents | 2019 |
Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial.
Topics: Adult; Double-Blind Method; Drug Monitoring; Female; Fetal Growth Retardation; Fetus; Gestational Age; Humans; Pentaerythritol Tetranitrate; Perfusion Imaging; Placenta; Placenta Diseases; Pregnancy; Treatment Outcome; Ultrasonography, Prenatal; Umbilical Arteries; Uterine Artery; Uterus; Vasodilator Agents | 2018 |
Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.
Topics: Abruptio Placentae; Double-Blind Method; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Nitric Oxide Donors; Pentaerythritol Tetranitrate; Perinatal Death; Placenta; Placenta Diseases; Placentation; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Prospective Studies; Ultrasonography, Prenatal; Uterine Artery; Vasodilator Agents | 2014 |
7 other study(ies) available for pentaerythritol tetranitrate and Pregnancy
| Article | Year |
|---|---|
Increased Cesarean Section Rates during the COVID-19 Pandemic: Looking for Reasons through the Robson Ten Group Classification System.
Topics: Cesarean Section; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Pandemics; Parturition; Pentaerythritol Tetranitrate; Pregnancy | 2023 |
The impact of maternal morbidity on cesarean section rates: exploring a Latin American network of sentinel facilities using the Robson's Ten Group Classification System.
Topics: Cesarean Section; Family; Female; Humans; Infant, Newborn; Latin America; Parturition; Pentaerythritol Tetranitrate; Pregnancy; Racial Groups | 2023 |
Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia.
Topics: Animals; Biomarkers; Blood Pressure; Disease Management; Disease Models, Animal; Disease Susceptibility; Female; Fetal Development; Glucose Tolerance Test; Insulin; Male; Maternal Exposure; Pentaerythritol Tetranitrate; Pre-Eclampsia; Pregnancy; Rats; Rats, Inbred Dahl; Vasodilator Agents | 2020 |
NO for the pregnant mother: no hypertension for the daughter?
Topics: Animals; Blood Pressure; Female; Hypertension; Male; Maternal Exposure; Pentaerythritol Tetranitrate; Pregnancy; Pregnancy, Animal; Vasodilation | 2015 |
Maternal treatment of spontaneously hypertensive rats with pentaerythritol tetranitrate reduces blood pressure in female offspring.
Topics: Animals; Animals, Newborn; Blood Pressure; DNA; Endothelium, Vascular; Female; Gene Expression Regulation, Developmental; Hypertension; Male; Maternal Exposure; Nitric Oxide Synthase Type III; Pentaerythritol Tetranitrate; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred SHR; Vasodilation; Vasodilator Agents | 2015 |
Reproductive and developmental effects and physical and chemical properties of pentaerythritol tetranitrate (PETN) in the rat.
Topics: 1-Octanol; Administration, Oral; Animals; Biodegradation, Environmental; Body Weight; Dose-Response Relationship, Drug; Environmental Exposure; Environmental Pollutants; Female; Fetal Development; Gonads; Male; Pentaerythritol Tetranitrate; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Sex Ratio; Solubility; Vasodilator Agents | 2009 |
Obstetrical anesthesia in myocardial infarction and complete heart block.
Topics: Adult; Anesthesia, Obstetrical; Female; Heart Block; Humans; Isoproterenol; Myocardial Infarction; Pacemaker, Artificial; Pentaerythritol Tetranitrate; Pregnancy; Pregnancy Complications, Cardiovascular | 1968 |